NeuroAI is redefining brain health with AI-powered diagnostics, personalized treatment plans, and real-time recovery monitoring. As we expand, we invite investors to be part of a high-growth opportunity in the multi-billion-dollar neurotechnology market.

• Massive Market Potential – Addressing concussion, Parkinson’s, cognitive decline, and sports injuries in a rapidly growing industry.
• First-to-Market AI Diagnostics – Combining machine learning, eye-tracking, and biometrics to revolutionize neurological assessments.
• Recurring Revenue Model – Subscription-based services, clinical partnerships, and research integrations ensure scalable growth.
• Regulatory & Clinical Backing – Aligning with FDA clearance pathways and global research studies for credibility and adoption.
• Strategic Partnerships – Collaborating with elite sports leagues, top research institutions, and leading healthcare providers.

🔹 Hardware + SaaS Subscription Model – Clinics, researchers, and sports organizations adopt our DX Goggles & AI analytics platform.

🔹 B2B & B2C Expansion – Broad reach into neurology clinics, sports medicine, telehealth, and corporate wellness programs.

🔹 Global Research & Data Monetization – Leveraging AI-driven neurological data for clinical studies & personalized treatments.

Investor Opportunities Available:

🔹 Series A Funding

🔹 Strategic Partnerships & Joint Ventures

🔹 Equity & Advisory Roles for Industry Leaders

Be part of the movement transforming brain health through AI.

➡️ Learn More & Get Involved